Fosforiano
de Gaullista
5.3.6 Cumulative Analysis
of Post-authorization
Adverse Event Reports
APPENDIX 1.
LIST OF ADVERSE EVENTS
OF SPECIAL INTEREST
1p36 deletion syndrome
2-Hydroxyglutaric aciduria
5’nucleotidase increased
Acoustic neuritis
Acquired C1 inhibitor deciency
Acquired epidermolysis bullosa
Acquired epileptic aphasia
Acute cutaneous lupus erythematosus
Acute disseminated encephalomyelitis
Acute encephalitis with refractory, repetitive
partial seizures
Acute febrile neutrophilic dermatosis
Acute accid myelitis
Acute haemorrhagic leukoencephalitis
Acute haemorrhagic oedema of infancy
Acute kidney injury
Acute macular outer retinopathy
Acute motor axonal neuropathy
Acute motor-sensory axonal neuropathy
Acute myocardial infarction
Acute respiratory distress syndrome
Acute respiratory failure;Addison’s disease
Administration site thrombosis
Administration site vasculitis
Adrenal thrombosis
Adverse event ***owing immunisation
Ageusia;Agranulocytosis
Air embolism
Alanine aminotransferase abnormal
Alanine aminotransferase increased
Alcoholic seizure
Allergic bronchopulmonary mycosis
Allergic oedema;Alloimmune hepatitis
Alopecia areata
Alpers disease
Alveolar proteinosis
Ammonia abnormal
Ammonia increased
Amniotic cavity infection
Amygdalohippocampectomy
Amyloid arthropathy
Amyloidosis
Amyloidosis senile
Anaphylactic reaction
Anaphylactic shock
Anaphylactic tras*fusion reaction
Anaphylactoid reaction
Anaphylactoid shock
Anaphylactoid syndrome of pregnancy
Angioedema
Angiopathic neuropathy
Ankylosing spondylitis
Anosmia
Antiacetylcholine receptor antibody positive
Anti-actin antibody positive
Anti-aquaporin-4 antibody positive
Anti-basal ganglia antibody positive
Anti-cyclic citrullinated peptide antibody
positive
Anti-epithelial antibody positive
Anti-erythrocyte antibody positive
Anti-exosome complex antibody positive
Anti- GAD antibody negative
Anti-GAD antibody positive
Anti-ganglioside antibody positive
Antigliadin antibody positive
Anti-glomerular basement membrane anti-
body positive
Anti-glomerular basement membrane dis-
ease
Anti-glycyl-tRNA synthetase antibody posi-
tive
Anti-HLA antibody test positive
Anti-IA2 antibody positive
Anti-insulin antibody increased
Anti-insulin antibody positive
Anti-insulin receptor antibody increased
Anti-insulin receptor antibody positive
Anti-interferon antibody negative
Anti-interferon antibody positive
Anti-islet cell antibody positive
358266490_FOIA_Release_-_536_Cumulative_Analysis_of_Post-authorization_Adverse_Event_Reports_EXPLOSIVE_List_of_100s_of_known_adverse_events_for_the_Pfizer_CoV-2_Injections
of Post-authorization
Adverse Event Reports
APPENDIX 1.
LIST OF ADVERSE EVENTS
OF SPECIAL INTEREST
1p36 deletion syndrome
2-Hydroxyglutaric aciduria
5’nucleotidase increased
Acoustic neuritis
Acquired C1 inhibitor deciency
Acquired epidermolysis bullosa
Acquired epileptic aphasia
Acute cutaneous lupus erythematosus
Acute disseminated encephalomyelitis
Acute encephalitis with refractory, repetitive
partial seizures
Acute febrile neutrophilic dermatosis
Acute accid myelitis
Acute haemorrhagic leukoencephalitis
Acute haemorrhagic oedema of infancy
Acute kidney injury
Acute macular outer retinopathy
Acute motor axonal neuropathy
Acute motor-sensory axonal neuropathy
Acute myocardial infarction
Acute respiratory distress syndrome
Acute respiratory failure;Addison’s disease
Administration site thrombosis
Administration site vasculitis
Adrenal thrombosis
Adverse event ***owing immunisation
Ageusia;Agranulocytosis
Air embolism
Alanine aminotransferase abnormal
Alanine aminotransferase increased
Alcoholic seizure
Allergic bronchopulmonary mycosis
Allergic oedema;Alloimmune hepatitis
Alopecia areata
Alpers disease
Alveolar proteinosis
Ammonia abnormal
Ammonia increased
Amniotic cavity infection
Amygdalohippocampectomy
Amyloid arthropathy
Amyloidosis
Amyloidosis senile
Anaphylactic reaction
Anaphylactic shock
Anaphylactic tras*fusion reaction
Anaphylactoid reaction
Anaphylactoid shock
Anaphylactoid syndrome of pregnancy
Angioedema
Angiopathic neuropathy
Ankylosing spondylitis
Anosmia
Antiacetylcholine receptor antibody positive
Anti-actin antibody positive
Anti-aquaporin-4 antibody positive
Anti-basal ganglia antibody positive
Anti-cyclic citrullinated peptide antibody
positive
Anti-epithelial antibody positive
Anti-erythrocyte antibody positive
Anti-exosome complex antibody positive
Anti- GAD antibody negative
Anti-GAD antibody positive
Anti-ganglioside antibody positive
Antigliadin antibody positive
Anti-glomerular basement membrane anti-
body positive
Anti-glomerular basement membrane dis-
ease
Anti-glycyl-tRNA synthetase antibody posi-
tive
Anti-HLA antibody test positive
Anti-IA2 antibody positive
Anti-insulin antibody increased
Anti-insulin antibody positive
Anti-insulin receptor antibody increased
Anti-insulin receptor antibody positive
Anti-interferon antibody negative
Anti-interferon antibody positive
Anti-islet cell antibody positive
358266490_FOIA_Release_-_536_Cumulative_Analysis_of_Post-authorization_Adverse_Event_Reports_EXPLOSIVE_List_of_100s_of_known_adverse_events_for_the_Pfizer_CoV-2_Injections
